previous arrow
Gold Award at the 28th National Invention Exhibition 榮獲第28屆全國發明展覽會、”一帶一路”暨金磚國家技能發展與技術創新大賽金獎 , 12-13 Dec 2024
Gold Award at the 28th National Invention Exhibition 榮獲第28屆全國發明展覽會、”一帶一路”暨金磚國家技能發展與技術創新大賽金獎 , 12-13 Dec 2024
Congratulation to The Centre for Clinical Research and Biostatistics (CCRB) of the Chinese University of Hong Kong, which has won the Gold Award in the 28th National Invention Exhibition cum Belt & Road and BRICS Competition of Skills Development and Technology Innovation. The title of the awarded project is “AI-based Retinal Image Analysis for Blood Glucose Health Risk.”

祝賀香港中文大學臨床研究與生物統計中心(CCRB)榮獲第28屆全國發明展覽會、”一帶一路”暨金磚國家技能發展與技術創新大賽金獎。獲獎項目的標題是「針對血糖健康風險的人工智能視網膜影像分析技、
Winner of Prudential Tech Showcase at the Insurtech Insights Asia 2024 - 4-5 Dec 2024
Winner of Prudential Tech Showcase at the Insurtech Insights Asia 2024 - 4-5 Dec 2024
Congratulation to Health View Bioanalytic Limited being selected as a Winner of the Prudential Tech Showcase in the Insurtech Insights ASIA 2024 held at the Kerry Hotel on 4-5 Dec. The juries of the Tech Showcase, composed of insurance association heads and executives, were searching for technology-powered companies that are addressing significant challenges, have built outstanding solutions, are seeing strong traction in the market, and are fundamentally transforming insurance for good. In addition, I have joined a panel discussion on the topic "Beyond Financial Protection: The Role of Health Insurance in Wellness Innovation", and we have set up a booth with real-life demos, providing a first-hand experience with the technology.
Suffering from depression? Hong Kong team can help with AI and by looking into your eyes, 2 Sep 2024
Suffering from depression? Hong Kong team can help with AI and by looking into your eyes - 2 Sep 2024
SCMP : Chinese University scientists have discovered an affordable way to estimate the risk of depression in people by harnessing artificial intelligence to analyse retinal images.
BOC Life 9th Golden Age Expo & Summit, 2-4 August 2024
BOC Life 9th Golden Age Expo & Summit, 2-4 August 2024
The BOC Life 9th Golden Age Expo and Summit was held at the Hong Kong Convention & Exhibition Centre Hall 3FG from 2 to 4 August 2024. We showcased the latest smart ageing technologies, innovative products, and services under the theme: “Sustainable Smart Ageing.” We partnered with BOC Life to showcase and demonstrate the AI-based Retinal Image Analysis (ARIA) technology with BOC Life to create a strong synergy to provide better services for the ageing community.

Prof Benny Zee, Director of the Centre for Clinical Research and Biostatistics (CCRB) of CUHK, received the "Smart Ageing Leader Award 2024 for Smart Ageing Champion (Technology)" at the Golden Age Foundation Galla Dinner this year.
2024年創新科技獎項嘉許禮
2024年創新科技獎項嘉許禮 – 15 July 2024
為表揚香港創科界過去一年榮獲多個國際或內地的創科重要獎項,行政長官李家超出席由創新科技署舉辦以「香港創科成就 揚威世界舞台」為主題的嘉許禮。有超過300個得獎者及團隊出席典禮。
CCRB won two Gold Medals
CCRB won two Gold Medals and a Special Award in the 49th International Exhibition of Inventions Geneva, 16-20 April 2024
The International Exhibition of Inventions Geneva (IEIG) is the world’s largest annual event devoted exclusively to inventions and the licensing market. This year, more than 1000 exhibitors from 45 countries presented their exclusive inventions, research, and new products. The Centre for Clinical Research and Biostatistics (CCRB) has won a Special Award: “Prize of Korean Invention Promotion Association (KIPA)”, and a “Gold Medal with Congratulation of the Jury” for the Project: “AI Retinal Image Analysis for the Risk of Autism (ASD) and Global Developmental Delay (GDD) in Preschoolers“. Another Gold Medal for the Project: “AI-based Automatic Retinal Image Analysis (ARIA) for Detecting Depression Risk in Adults
CCRB developed a computational model
CCRB developed a computational model to accurately forecast viral genetic evolution, 2 May 2024
The Centre for Clinical Research and Biostatistics (CCRB) has developed a computational model, beth-1, to predict genetic evolution in viruses and select representative strains for influenza vaccines. The model estimates virus changes and can potentially facilitate optimal vaccine strain selection, enhancing the protective effect of influenza vaccines.
创业之星
杨浦创业之星大赛「创业之星」奖, 22 March 2024
香港中文大学研发的视网膜图像分析技术,作为解决未确诊的糖尿病的方法。未确诊的糖尿病是一个全球性的健康问题,大约24%–75%病例未被诊断,因此导致大量糖尿病并发症和巨额医疗费用。目前许多糖尿病诊断方法依赖于代谢指数,并且存在相当大的变异性。相比之下,视网膜图像分析以数字方法表述了整体血糖状态,提供一个稳定的标记,而且快速、方便、及非侵入性,超过90%的敏感性和特异性。

Yangpu Entrepreneurship Star Competition “Entrepreneurship Star” Award, 22 March 2024

Automatic Retinal Image Analysis (ARIA)
CCRB developed a computational model
CCRB and HVB won a silver award at the International Invention Fair in the Middle East (4-7 Feb 2024)
Centre for Clinical Research and Biostatistics (CCRB) and Health View Bioanalytic Limited (HVB) joined the International Invention Fair in the Middle East in February 2024. ARIA-diabetes risk was submitted and won a silver award in the IIFME competition. It analyzes retinal images to assess the risk of diabetes in a non-invasive and convenient manner and with an exceptional accuracy of over 90%. This is particularly suitable for population-based screening for diabetes and prediabetes and is an ideal solution to undiagnosed diabetes.
CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV, 23 March 2023
CUHK develops an efficient approach to estimate the risk of heart disease in people living with HIV, 23 March 2023
CUHK has evaluated the effectiveness of a simple tool – Automatic Retinal Image Analysis (ARIA) technology – for assessing cardiovascular risk in people with HIV. Results incorporate both retinal characteristics and traditional cardiovascular risk factors, having a sensitivity and a specificity of over 90% in assessing the presence of obstructive coronary artery disease.
next arrow

Research

Medical research into design methodology and analysis of clinical trials

Innovation

Combining innovation and research into entrepreneurship of the next generation

Services

Support with sound design methodology and analysis of clinical trials

Training

The CCRB is dedicated to educate clinical research community.

Centre for Clinical Research Biostatistics – Clinical Trials Registry (CCRBCTR)

The Centre for Clinical Research and Biostatistics – Clinical Trials Registry (CCRBCTR), provides all prospective registrants with a convenient means to submit trial registration for all countries. Registered information is displayed in English only (except for the Chinese study title) and is accessible to the public at no charge. Fees would only apply to services other than clinical trials registration, such as translation of registered information. All trial registrations are electronically searchable with an in-house mechanism to ensure the validity of the registration data. With the updated webpage, the registrants can manage all their registrations with one login account and the public can access the audit trail for all registration amendments.

Since December 2009, the Centre for Clinical Research & Biostatistics, Clinical Trials Registry – CUHK is a Partner Registry of a WHO Primary Registry – Chinese Clinical Trials Registry (ChiCTR).We gather trial information and make the information available in the WHO trial registration dataset, so trials registered on our registry are now also registered on ChiCTR with registration numbers from the WHO Primary Registry and all registered information in CCRBCTR is publicly searchable at WHO ICTRP and ChiCTR, Centre for Clinical Research and Biostatistics, Clinical Trials Registry of Chinese University of Hong Kong is now in compliance with WHO ICTRP and ICMJE trial registration requirements and it satisfies the requirements of many major journals.

Clinical Trials Registration Instruction

User Account Registration

Clinical Trial Registry User Login

View Clinical Trial Registration